Evidence map›Paper›PMID 31796060›Full record

SynthesisGenome medicine2019

Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.

Jake Lever, Martin R Jones, Arpad M Danos, Kilannin Krysiak, Melika Bonakdar, Jasleen K Grewal, Luka Culibrk, Obi L Griffith, Malachi Griffith, Steven J M Jones

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Genome medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jake LeverCanada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Martin R JonesCanada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Arpad M DanosMcDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
Kilannin KrysiakMcDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
Melika BonakdarCanada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Jasleen K GrewalCanada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Luka CulibrkCanada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Obi L GriffithMcDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA. obigriffith@wustl.edu.
Malachi GriffithMcDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA. mgriffit@wustl.edu.
Steven J M JonesCanada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada. sjones@bcgsc.ca.ORCID 0000-0003-3394-2208
James S. McDonnell Foundation · USUniversity of British Columbia · CACanada's Michael Smith Genome Sciences Centre · CA

Funding

Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision MedicineU24CA237719 · NCI · WASHINGTON UNIVERSITY · PI GRIFFITH, OBI L. · 2019 to 2023
$3.8M
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCERU01CA209936 · NCI · WASHINGTON UNIVERSITY · PI GRIFFITH, OBI L. · 2016 to 2018
$1.0M
Integrated Analysis & Interpretation of Whole Genome Exome & Transcriptome SequenR00HG007940 · NHGRI · WASHINGTON UNIVERSITY · PI GRIFFITH, MALACHI · 2017 to 2019
$724k
NCI NIH HHS U01 CA209936NCI NIH HHS U24 CA237719NHGRI NIH HHS R00 HG007940NHGRI NIH HHS R00HG007940NIH HHS U01CA209936
6 · The paper itself

Abstract

backgroundPrecision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing, and drug response markers is essential. Several knowledgebases have been created by different groups to collate evidence for these associations. These include the open-access Clinical Interpretation of Variants in Cancer (CIViC) knowledgebase. These databases rely on time-consuming manual curation from skilled experts who read and interpret the relevant biomedical literature.

methodsTo aid in this curation and provide the greatest coverage for these databases, particularly CIViC, we propose the use of text mining approaches to extract these clinically relevant biomarkers from all available published literature. To this end, a group of cancer genomics experts annotated sentences that discussed biomarkers with their clinical associations and achieved good inter-annotator agreement. We then used a supervised learning approach to construct the CIViCmine knowledgebase.

resultsWe extracted 121,589 relevant sentences from PubMed abstracts and PubMed Central Open Access full-text papers. CIViCmine contains over 87,412 biomarkers associated with 8035 genes, 337 drugs, and 572 cancer types, representing 25,818 abstracts and 39,795 full-text publications.

conclusionsThrough integration with CIVIC, we provide a prioritized list of curatable clinically relevant cancer biomarkers as well as a resource that is valuable to other knowledgebases and precision cancer analysts in general. All data is publically available and distributed with a Creative Commons Zero license. The CIViCmine knowledgebase is available at http://bionlp.bcgsc.ca/civicmine/.

Indexed as

Biomarkers, TumorDatabases, FactualData MiningDisease ManagementHumansMachine LearningMedical InformaticsNeoplasmsPrecision MedicineUser-Computer InterfaceBiomarkers, TumorCancer biomarkersInformation extractionMachine learningPrecision oncologyText mining

Identifiers

PMID31796060
PMCPMC6891984
OpenAlexW2993172114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.